放射線皮膚炎の世界市場の規模と予測:製品別(局所用、コルチコステロイド、親水性クリーム、抗生物質、ドレッシング、ヒドロゲル・親水コロイド、無刺激バリアフィルム、シリコーンコーティング)、流通経路別、セグメント予測、2014-2025...市場調査レポートについてご紹介

【英文タイトル】Radiodermatitis Market Analysis By Product (Topical, Corticosteroids, Hydrophilic Creams, Antibiotics, Dressings, Hydrogel & Hydrocolloid, No Sting Barrier Film, Silicone Coated), By Distribution Channel, And Segment Forecasts, 2014-2025

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Chapter 1 Research Methodology & Scope
1.1 Region Wise Market Calculation
1.1.1 Region-wise market: Base estimates
1.1.2 Global market: CAGR calculation
1.2 Region-Based Segment Share Calculation
1.3 List of Secondary Sources
Chapter 2 Executive Summary
Chapter 3 Radiodermatitis Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.2 Market Driver Analysis
3.3 Market Restraint Analysis
3.4 Penetration & Growth Prospect Mapping
3.5 Radiodermatitis Market – SWOT Analysis, By Factor (Political & legal, economic and technological)
3.6 Industry Analysis – Porter’s
Chapter 4 Radiodermatitis Market: Product Estimates & Trend Analysis
4.1 Radiodermatitis Market: Product Movement Analysis
4.2 Topical
4.2.1 Topical market estimates and forecasts, 2014 – 2025 (USD Million)
4.2.2 Corticosteroids
4.2.2.1 Corticosteroids market estimates and forecasts, 2014 – 2025 (USD Million)
4.2.3 Hydrophilic creams
4.2.3.1 Hydrophilic creams market estimates and forecasts, 2014 – 2025 (USD Million)
4.2.4 Antibiotics
4.2.4.1 Antibiotics market estimates and forecasts, 2014 – 2025 (USD Million)
4.2.5 Others
4.2.5.1 Others market estimates and forecasts, 2014 – 2025 (USD Million)
4.3 Oral
4.3.1 Oral market estimates and forecasts, 2014 – 2025 (USD Million)
4.4 Dressings
4.4.1 Dressings market estimates and forecasts, 2014 – 2025 (USD Million)
4.4.2 Hydrogel & hydrocolloid dressing
4.4.2.1 Hydrogel & hydrocolloid dressing market estimates and forecasts, 2014 – 2025 (USD Million)
4.4.3 No sting barrier film
4.4.3.1 No sting barrier film market estimates and forecasts, 2014 – 2025 (USD Million)
4.4.4 Honey impregnated gauze
4.4.4.1 Honey impregnated gauze market estimates and forecasts, 2014 – 2025 (USD Million)
4.4.5 Silicone coated dressings
4.4.5.1 Silicone coated dressings market estimates and forecasts, 2014 – 2025 (USD Million)
4.4.6 Others
4.4.6.1 Others market estimates and forecasts, 2014 – 2025 (USD Million)
Chapter 5 Radiodermatitis Market: Distribution Channel Estimates & Trend Analysis
5.1 Radiodermatitis Market: Distribution Channel Movement Analysis
5.2 Hospital Pharmacy
5.2.1 Hospital pharmacy market estimates and forecasts, 2014 – 2025 (USD Million)
5.3 Retail Pharmacy
5.3.1 Retail pharmacy estimates and forecasts, 2014 – 2025 (USD Million)
5.4 Online Pharmacies
5.4.1 Online pharmacies market estimates and forecasts, 2014 – 2025 (USD Million)
Chapter 6 Radiodermatitis Market: Regional Estimates & Trend Analysis, by Product & Distribution Channel
6.1 Radiodermatitis Market Shares By Region, 2016 & 2025
6.2 North America
6.2.1 North America radiodermatitis market, by product, 2014 – 2025 (USD Million)
6.2.2 North America radiodermatitis market, by distribution channel, 2014 – 2025 (USD Million)
6.2.3 U.S.
6.2.3.1 U.S. radiodermatitis market, by product, 2014 – 2025 (USD Million)
6.2.3.2 U.S. radiodermatitis market, by distribution channel, 2014 – 2025 (USD Million)
6.2.4 Canada
6.2.4.1 Canada radiodermatitis market, by product, 2014 – 2025 (USD Million)
6.2.4.2 Canada radiodermatitis market, by distribution channel, 2014 – 2025 (USD Million)
6.3 Europe
6.3.1 Europe radiodermatitis market, by product, 2014 – 2025 (USD Million)
6.3.2 Europe radiodermatitis market, by distribution channel, 2014 – 2025 (USD Million)
6.3.3 UK
6.3.3.1 UK radiodermatitis market estimates and forecasts, 2014 – 2025(USD Million)
6.3.3.2 UK radiodermatitis market, by product, 2014 – 2025 (USD Million)
6.3.3.3 UK radiodermatitis market, by distribution channel, 2014 – 2025 (USD Million)
6.3.4 Germany
6.3.4.1 Germany radiodermatitis market, by product, 2014 – 2025 (USD Million)
6.3.4.2 Germany radiodermatitis market, by distribution channel, 2014 – 2025 (USD Million)
6.4 Asia Pacific
6.4.1 Asia Pacific radiodermatitis market, by product, 2014 – 2025 (USD Million)
6.4.2 Asia Pacific radiodermatitis market, by distribution channel, 2014 – 2025 (USD Million)
6.4.3 Japan
6.4.3.1 Japan radiodermatitis market, by product, 2014 – 2025 (USD Million)
6.4.3.2 Japan radiodermatitis market, by distribution channel, 2014 – 2025 (USD Million)
6.4.4 China
6.4.4.1 China radiodermatitis market, by product, 2014 – 2025 (USD Million)
6.4.4.2 China radiodermatitis market, by distribution channel, 2014 – 2025 (USD Million)
6.4.5 India
6.4.5.1 India radiodermatitis market, by product, 2014 – 2025 (USD Million)
6.4.5.2 India radiodermatitis market, by distribution channel, 2014 – 2025 (USD Million)
6.5 Latin America
6.5.1 Latin America radiodermatitis market, by product, 2014 – 2025 (USD Million)
6.5.2 Latin America radiodermatitis market, by distribution channel, 2014 – 2025 (USD Million)
6.5.3 Brazil
6.5.3.1 Brazil radiodermatitis market, by product, 2014 – 2025 (USD Million)
6.5.3.2 Brazil radiodermatitis market, by distribution channel, 2014 – 2025 (USD Million)
6.5.4 Mexico
6.5.4.1 Mexico radiodermatitis market, by product, 2014 – 2025 (USD Million)
6.5.4.2 Mexico radiodermatitis market, by distribution channel, 2014 – 2025 (USD Million)
6.6 MEA
6.6.1 MEA radiodermatitis market, by product, 2014 – 2025 (USD Million)
6.6.2 MEA radiodermatitis market, by distribution channel, 2014 – 2025 (USD Million)
6.6.3 South Africa
6.6.3.1 South Africa radiodermatitis market, by product, 2014 – 2025 (USD Million)
6.6.3.2 South Africa radiodermatitis market, by distribution channel, 2014 – 2025 (USD Million)
Chapter 7 Competitive Landscape
7.1 Strategy Framework
7.2 Market Participation Categorization
7.3 Company Profiles
7.3.1 Stratpharma AG
7.3.1.1 Company overview
7.3.1.2 Financial performance
7.3.1.3 Product benchmarking
7.3.1.4 Strategic initiatives
7.3.2 Smith & Nephew
7.3.2.1 Company Overview
7.3.2.2 Financial Performance
7.3.2.3 Product Benchmarking
7.3.2.4 Strategic initiatives
7.3.3 Molnlycke Health Care AB
7.3.3.1 Company Overview
7.3.3.2 Financial Performance
7.3.3.3 Product Benchmarking
7.3.3.4 Strategic initiatives
7.3.4 Derma Sciences Inc.
7.3.4.1 Company overview
7.3.4.2 Financial Performance
7.3.4.3 Product Benchmarking
7.3.4.4 Strategic initiatives
7.3.5 ConvaTec Inc.
7.3.5.1 Company overview
7.3.5.2 Financial performance
7.3.5.3 Product benchmarking
7.3.4.4 Strategic initiatives
7.3.6 BMG Pharma S.R.L.
7.3.6.1 Company overview
7.3.6.2 Financial performance
7.3.6.3 Product benchmarking
7.3.6.4 Strategic initiatives
7.3.7 Acelity
7.3.7.1 Company overview
7.3.7.2 Financial performance
7.3.7.3 Product benchmarking
7.3.7.4 Strategic initiatives
7.3.8 3M
7.3.8.1 Company Overview
7.3.8.2 Financial Performance
7.3.8.3 Product Benchmarking
7.3.9 Alliqua BioMedical
7.3.9.1 Company overview
7.3.9.2 Financial performance
7.3.9.3 Product benchmarking
7.3.4.4 Strategic initiatives


【レポート販売概要】

■ タイトル:放射線皮膚炎の世界市場の規模と予測:製品別(局所用、コルチコステロイド、親水性クリーム、抗生物質、ドレッシング、ヒドロゲル・親水コロイド、無刺激バリアフィルム、シリコーンコーティング)、流通経路別、セグメント予測、2014-2025
■ 英文:Radiodermatitis Market Analysis By Product (Topical, Corticosteroids, Hydrophilic Creams, Antibiotics, Dressings, Hydrogel & Hydrocolloid, No Sting Barrier Film, Silicone Coated), By Distribution Channel, And Segment Forecasts, 2014-2025
■ 発行日:2017年5月24日
■ 調査会社:Grand View Research
■ 商品コード:GVIEW707733
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。